These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26597680)

  • 1. Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments.
    Del Giudice I; Marinelli M; Wang J; Bonina S; Messina M; Chiaretti S; Ilari C; Cafforio L; Raponi S; Mauro FR; Di Maio V; De Propris MS; Nanni M; Ciardullo C; Rossi D; Gaidano G; Guarini A; Rabadan R; Foà R
    Br J Haematol; 2016 Feb; 172(3):371-383. PubMed ID: 26597680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.
    Nadeu F; Delgado J; Royo C; Baumann T; Stankovic T; Pinyol M; Jares P; Navarro A; Martín-García D; Beà S; Salaverria I; Oldreive C; Aymerich M; Suárez-Cisneros H; Rozman M; Villamor N; Colomer D; López-Guillermo A; González M; Alcoceba M; Terol MJ; Colado E; Puente XS; López-Otín C; Enjuanes A; Campo E
    Blood; 2016 Apr; 127(17):2122-30. PubMed ID: 26837699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia.
    Amin NA; Seymour E; Saiya-Cork K; Parkin B; Shedden K; Malek SN
    Clin Cancer Res; 2016 Sep; 22(17):4525-35. PubMed ID: 27060156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of adhesion molecules in B-cell chronic lymphocytic leukaemia: an analysis in lymphoid compartments--peripheral blood, bone marrow and lymph node.
    Nadkarni JJ; Perambakam SM; Rathore VB; Amin KM; Parikh PM; Naresh KN; Advani SH
    Cancer Biother Radiopharm; 1998 Aug; 13(4):269-74. PubMed ID: 10850362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemia.
    Jethwa A; Hüllein J; Stolz T; Blume C; Sellner L; Jauch A; Sill M; Kater AP; te Raa GD; Geisler C; van Oers M; Dietrich S; Dreger P; Ho AD; Paruzynski A; Schmidt M; von Kalle C; Glimm H; Zenz T
    Br J Haematol; 2013 Nov; 163(4):496-500. PubMed ID: 24032483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia.
    Sun C; Chen YC; Martinez Zurita A; Baptista MJ; Pittaluga S; Liu D; Rosebrock D; Gohil SH; Saba NS; Davies-Hill T; Herman SEM; Getz G; Pirooznia M; Wu CJ; Wiestner A
    Blood Adv; 2023 Jan; 7(1):145-158. PubMed ID: 35358998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibrutinib induces rapid down-regulation of inflammatory markers and altered transcription of chronic lymphocytic leukaemia-related genes in blood and lymph nodes.
    Palma M; Krstic A; Peña Perez L; Berglöf A; Meinke S; Wang Q; Blomberg KEM; Kamali-Moghaddam M; Shen Q; Jaremko G; Lundin J; De Paepe A; Höglund P; Kimby E; Österborg A; Månsson R; Smith CIE
    Br J Haematol; 2018 Oct; 183(2):212-224. PubMed ID: 30125946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.
    Landau DA; Carter SL; Stojanov P; McKenna A; Stevenson K; Lawrence MS; Sougnez C; Stewart C; Sivachenko A; Wang L; Wan Y; Zhang W; Shukla SA; Vartanov A; Fernandes SM; Saksena G; Cibulskis K; Tesar B; Gabriel S; Hacohen N; Meyerson M; Lander ES; Neuberg D; Brown JR; Getz G; Wu CJ
    Cell; 2013 Feb; 152(4):714-26. PubMed ID: 23415222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal evolution in chronic lymphocytic leukemia: impact of subclonality on disease progression.
    Sutton LA; Rosenquist R
    Expert Rev Hematol; 2015 Feb; 8(1):71-8. PubMed ID: 25345442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.
    Mittal AK; Chaturvedi NK; Rai KJ; Gilling-Cutucache CE; Nordgren TM; Moragues M; Lu R; Opavsky R; Bociek GR; Weisenburger DD; Iqbal J; Joshi SS
    Mol Med; 2014 Jul; 20(1):290-301. PubMed ID: 24800836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin-1.
    Gilling CE; Mittal AK; Chaturvedi NK; Iqbal J; Aoun P; Bierman PJ; Bociek RG; Weisenburger DD; Joshi SS
    Br J Haematol; 2012 Jul; 158(2):216-231. PubMed ID: 22571278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic lymphocytic leukemia with paraimmunoblastic transformation - with comparative genomic hybridization and review of the literature.
    Chuang SS; Liao YL; Liou CP; Wiggins ML; Ye H; Du MQ; Isaacson PG; Chang CC
    Pathol Res Pract; 2010 Apr; 206(4):276-81. PubMed ID: 19433347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing of the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease development.
    Zaborsky N; Gassner FJ; Höpner JP; Schubert M; Hebenstreit D; Stark R; Asslaber D; Steiner M; Geisberger R; Greil R; Egle A
    Leukemia; 2019 Apr; 33(4):957-968. PubMed ID: 30262843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma.
    Moia R; Favini C; Ferri V; Forestieri G; Terzi Di Bergamo L; Schipani M; Sagiraju S; Andorno A; Rasi S; Adhinaveni R; Talotta D; Al Essa W; De Paoli L; Margiotta Casaluci G; Patriarca A; Boldorini RL; Rossi D; Gaidano G
    Br J Haematol; 2021 Oct; 195(1):108-112. PubMed ID: 34291829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia.
    Nadeu F; Clot G; Delgado J; Martín-García D; Baumann T; Salaverria I; Beà S; Pinyol M; Jares P; Navarro A; Suárez-Cisneros H; Aymerich M; Rozman M; Villamor N; Colomer D; González M; Alcoceba M; Terol MJ; Navarro B; Colado E; Payer ÁR; Puente XS; López-Otín C; López-Guillermo A; Enjuanes A; Campo E
    Leukemia; 2018 Mar; 32(3):645-653. PubMed ID: 28924241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal image analysis of chronic leukemic lymphoproliferative disorders and the hypothesis of "single" and "multiple" programmed stops in the development of typical and atypical forms of leukemias and lymphomas.
    Kardum-Skelin I; Puskarić BJ; Radić-Kristo D; Jaksić O; Kardum M; Jaksić B
    Coll Antropol; 2010 Jun; 34(2):367-76. PubMed ID: 20698104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities.
    Falisi E; Novella E; Visco C; Guercini N; Maura F; Giaretta I; Pomponi F; Nichele I; Finotto S; Montaldi A; Neri A; Rodeghiero F
    Hematol Oncol; 2014 Mar; 32(1):22-30. PubMed ID: 23861036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations driving CLL and their evolution in progression and relapse.
    Landau DA; Tausch E; Taylor-Weiner AN; Stewart C; Reiter JG; Bahlo J; Kluth S; Bozic I; Lawrence M; Böttcher S; Carter SL; Cibulskis K; Mertens D; Sougnez CL; Rosenberg M; Hess JM; Edelmann J; Kless S; Kneba M; Ritgen M; Fink A; Fischer K; Gabriel S; Lander ES; Nowak MA; Döhner H; Hallek M; Neuberg D; Getz G; Stilgenbauer S; Wu CJ
    Nature; 2015 Oct; 526(7574):525-30. PubMed ID: 26466571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexisting genomic aberrations associated with lymph node metastasis in breast cancer.
    Bao L; Qian Z; Lyng MB; Wang L; Yu Y; Wang T; Zhang X; Yang H; Brünner N; Wang J; Ditzel HJ
    J Clin Invest; 2018 Jun; 128(6):2310-2324. PubMed ID: 29558370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.